Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NIQUITIN 2 MG COMPRIMIDOS PARA CHUPAR SABOR LIMON - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/NIQUITIN 2 MG COMPRIMIDOS PARA CHUPAR SABOR LIMON

Approved

STANDARD

NIQUITIN 2 MG COMPRIMIDOS PARA CHUPAR SABOR LIMON

Perrigo Espana S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 14, 2021
Approval ID: ad195e92f1c3a5dc
Company: Perrigo Espana S.A.
Type: Standard

Approval Details

Approval Id: ad195e92f1c3a5dc
Drug Cima Aemps Name: NIQUITIN 2 MG COMPRIMIDOS PARA CHUPAR SABOR LIMON
Register Number: 86020
Holder Company Name: Perrigo Espana S.A.
Marketing Company Name: Perrigo Espana S.A.
Authorization Date: 2021-06-14
Dosage Form: COMPRIMIDO PARA CHUPAR
Dose: 2 mg
Route Of Administration: Vía bucal (buccal use)
Prescription Type: Sin Receta
Commercialized: No
Company Name: Perrigo Espana S.A.

Active Ingredients

NICOTINA RESINATO

13,33 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 14, 2021

Approval ID

ad195e92f1c3a5dc

Type

Standard

Back to CIMA-AEMPS Approvals